Xenon Pharmaceuticals Inc.
XENE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$91 | -$85 | -$65 | -$66 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | -$0 | -$1 | -$9 |
| Stock-Based Comp. | $14 | $14 | $12 | $14 |
| Change in WC | -$0 | $3 | -$12 | $2 |
| Other Non-Cash | $5 | $4 | $4 | $3 |
| Operating Cash Flow | -$72 | -$64 | -$62 | -$54 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$89 | -$131 | -$66 |
| Inv. Sales/Matur. | $0 | $171 | $166 | $166 |
| Other Inv. Act. | $39 | $0 | $0 | $0 |
| Investing Cash Flow | $39 | $82 | $35 | $99 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $1 | $12 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | -$0 | $0 | $0 |
| Financing Cash Flow | $2 | $0 | $1 | $12 |
| Forex Effect | -$0 | $1 | -$0 | -$1 |
| Net Chg. in Cash | -$31 | $19 | -$26 | $55 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $135 | $117 | $143 | $88 |
| End Cash | $105 | $135 | $117 | $143 |
| Free Cash Flow | -$72 | -$64 | -$62 | -$55 |